Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease

References

• Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230–47.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393–5.
   PubMed Web of Science ®Google Scholar
• Muller-Sieburg CE, Deryugina E. The stromal cells' guide to the stem cell universe. Stem Cells 1995;13:477–86.
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, . Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425:836–41.
   PubMed Web of Science ®Google Scholar
• Haynesworth SE, Baber MA, Caplan AI. Cytokine espression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996;166:585–92.
   PubMed Web of Science ®Google Scholar
• Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, . Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of selecta muscle and dermis derived from fetal adult and geriatric donors. Anat Rec 2001;264:51–62.
   PubMedGoogle Scholar
• Im G-I, Shin Y-W, Lee K-B. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?. Osteoarthritis Cartilage 2005;13:845–53.
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Roberts IA, Kumar S, Bennet PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood liver, and bone marrow. Blood 2001;98:2396–402.
   PubMed Web of Science ®Google Scholar
• in ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22:1338–45.
   PubMed Web of Science ®Google Scholar
• Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004;22:625–34.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non specific mitogenic stimuli. Blood 2002;99:3838–43.
   PubMed Web of Science ®Google Scholar
• Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, . Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favours the differentiation of CD4+ T-cell subsets expressing regulatory/suppressive phenotype. Haematologica 2005;90:516–25.
   PubMedGoogle Scholar
• Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, . Human mesenchymal stem cells modulate B cell functions. Blood 2006;107:367–72.
   PubMed Web of Science ®Google Scholar
• Spaggiari MG, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107:1484–90.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Maccario R and Frassoni F. Mesenchymal stromal cells from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?. Haematologica 2007;92:872–7.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc O, Devine S, Curtin P, Maziarz RT, Holland HK, . Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoieitc stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389–98.
   PubMed Web of Science ®Google Scholar
• Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, EEEgeler RM, . Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation. Blood 2007;110:2764–7.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, . Treatment of severe graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579–86.
   PubMed Web of Science ®Google Scholar
• Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, . MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002;7:113–7.
   PubMedGoogle Scholar
• Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, . Mesenhymal stem cell-drived molecules reverse fulminant hepatic failure. PLos ONE 2007;2:e941.
   PubMed Web of Science ®Google Scholar
• Ringdén O, Uzunel M, Sundberg B, Lönnies L, Nava S, Gustafsson J, . Tissue repair using mesenchymal stem cells for hemorrhagic cystitis pneumomediastinum and perforated colon. Luekemia 2007;21:2271–6.
   PubMed Web of Science ®Google Scholar
• Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004;18:463–79.
   PubMed Web of Science ®Google Scholar
• Baumgart D, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627–40.
   PubMed Web of Science ®Google Scholar
• Egan LJ, Sandborn WJ. Advances in the treatment of Crohn's disease. Gastroenterology 2004;126:1574–81.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Tsuji S, Tsujii M, Nishida T, Ishii S, Iijima H, . Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther 2008;326:523–31.
   PubMed Web of Science ®Google Scholar
• García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005;48:1416–23.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, . Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 2007;211:121–30.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, . Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67:9142–9.
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, . Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Emons JAM, Nauta AJ, Roelofs H, Romeo S, Marchini A, . Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res 2007;48:132–40.
   PubMed Web of Science ®Google Scholar
• in't Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL. Mesenchymal stem cells in human second-trimester bone marrow liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88:845–52.
   PubMed Web of Science ®Google Scholar
• de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM, . Diagnostic genome profiling in mental retardation. Am J Hum Genet 2005;77:606–16.
   PubMed Web of Science ®Google Scholar
• Nayar M, Rhodes JM. Management of inflammatory bowel disease. Postgrad Med J 2004;80:206–13.
   PubMed Web of Science ®Google Scholar
• Duijvestein M, van den Brink GR, Hommes DW. Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. J Crohns Colitis 2008;2:99–106.
   Google Scholar
• Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: moving toward a stem cell-based therapy. World J Gastroenterol 2008;14:4616–26.
   PubMed Web of Science ®Google Scholar
• MacDonald T, Hutchings P, Choy M, Murch S, Cooke A. Tumor necrosis factor-alpha and interferon gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301–5.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890–6.
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells Blood 2007;110:3499–506.
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114–20.
   PubMed Web of Science ®Google Scholar
• Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a Natural Killer cell?. Nature Immunology 2002;3:6–8.
   PubMed Web of Science ®Google Scholar
• Vermeesch JR, Melotte C, Froyen G, Van Vooren S, Dutta B, Maas N, . Molecular karyotyping: array CGH quality criteria for constitutional genetic diagnosis. J Histochem Cytochem 2005;53:413–22.
   PubMed Web of Science ®Google Scholar
• Okamoto R, Yajima T, Yamazaki M, Kanai T, Mukai M, Okamoto S, . Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 2002;8:1011–7.
   PubMed Web of Science ®Google Scholar
• Brittan M, Hunt T, Jeffery R, Poulsom R, Forbes SJ, Hodivala-Dilke K, . Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002;50:752–7.
   PubMed Web of Science ®Google Scholar
• Komori M, Tsuji S, Tsujii M, Murata H, Iijima H, Yasumaru M, . Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen 2005;13:109–18.
   Google Scholar
• Aggarwal S, Pittinger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815–22.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341–7.
   PubMed Web of Science ®Google Scholar
• Cellerix S. www.cellerix.com 2007.
   Google Scholar
• Taupin P. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs 2006;7:473–81.
   PubMedGoogle Scholar
• Osiris Therapeutics I. Evaluation of PROCHYMAL[tm] Adult Human Stem Cells for Treatment-Resistant Moderate-toSevere Crohn's Disease.www.clinicaltrials.gov NCT00482092 ed. 2007.
   Google Scholar
• Rubio D, Gracia-Olmo J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, . Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035–9.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, . Isolated allogeneic bone marrow derived mesenchymal stem cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932–7.
   PubMed Web of Science ®Google Scholar
• Gauche C, Scholmerich J, Brynshow J, D'Haens G, Hanauer SB, Irvine EJ, . simple classification of Crohn's disease: report of the working party of the world congresses of grastroenterology, Wien 1998. Inflamm Bowel Dis 2000;6:8–15.
   Google Scholar